论文信息 - OMIXCARE: OMICS technologies solved about 33% of the patients with heterogeneous rare neuro-developmental disorders and negative exome sequencing results and identified 13% additional candidate variants - 字舞流文

OMIXCARE: OMICS technologies solved about 33% of the patients with heterogeneous rare neuro-developmental disorders and negative exome sequencing results and identified 13% additional candidate variants

A. Afenjar | A. Boland | J. Deleuze | E. Colin | L. Faivre | C. Philippe | C. Thauvin-Robinet | Y. Duffourd | B. Isidor | É. Tisserant | R. Olaso | B. Sadikovic | S. Moutton | P. Callier | S. Odent | D. Heron | C. Mignot | B. Keren | A. Faudet | P. Charles | J. Kerkhof | M. Vincent | A. Bruel | Yvan Herenger | N. Jean-Marçais | M. Chevarin | Anne-Sophie Denommé-Pichon | Valentin Bourgeois | J. Delanne | A. Sorlin | A. Vitobello | S. Heide | H. McConkey | Hana Safraou | R. Relator | F. Tran Mau-Them | Charlotte Pöe | Victor Couturier | Y. Herenger | C. Pöe | A. Denommé-Pichon | H. Mcconkey